Skip to main content

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Archive
    • Subject Collections
    • Special Collections
  • Reviews & Opinions
    • Editorials
    • Found in Translation
    • Insights
    • People & Ideas
    • Perspectives
    • Reviews
    • Viewpoints
  • Alerts
  • About
    • History
    • Editors & Staff
    • Policies & Permissions
    • Advertise
    • Contact Us
    • Privacy Policy
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Publication Fees
    • Author Services
  • Subscriptions
  • Rockefeller University Press
  • JCB
  • JEM
  • JGP
  • LSA

User menu

  • Log in

Search

  • Advanced search
JEM
  • Rockefeller University Press
  • JCB
  • JEM
  • JGP
  • LSA
  • Log in
JEM

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Archive
    • Subject Collections
    • Special Collections
  • Reviews & Opinions
    • Editorials
    • Found in Translation
    • Insights
    • People & Ideas
    • Perspectives
    • Reviews
    • Viewpoints
  • Alerts
  • About
    • History
    • Editors & Staff
    • Policies & Permissions
    • Advertise
    • Contact Us
    • Privacy Policy
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Publication Fees
    • Author Services
  • Subscriptions

You are here

jem Home » 2008 Archive » 29 September » 205 (10): 2183.1
In This Issue

The lowdown on sugar highs

Hema Bashyam
Hema Bashyam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1084/jem.20510iti4 | Published September 22, 2008
  • Article
  • Info
  • Metrics
  • Preview PDF
Loading


Embedded Image

Cells exposed to high glucose (HG) levels overexpress NF-κB due to histone modifications of the NF-κB promoter by the enzyme Set7.

Short-lived sugar highs might give a quick energy boost, but according to El-Osta et al. (page 2409), they also leave a lasting bad impression on heart vessels of diabetes patients. The findings might explain why diabetics are at higher risk for heart disease.

Diabetes is a major cause of heart attack and stroke—events that are triggered by atherosclerotic plaques and inflammation in the arteries. In diabetic patients who have had extended periods of high blood glucose levels, arterial damage persists long after insulin therapy reduces their mean glucose levels. The authors now provide a molecular explanation for this phenomenon.

The group found that short-lived sugar highs, which occur even in insulin-treated diabetics, trigger histone modifications—an established effect of long-lasting sugar highs. Persistently high sugar levels are known to create reactive oxygen species that induce the generation of methylglyoxal—an activator of the histone methylating enzyme Set7. The authors found that brief blood sugar peaks also activated Set7, which bound to the promoter of the gene for NF-κB, thereby increasing its expression. NF-κB then switched on genes for proteins that help recruit and attach plaque-forming monocytes to vessel walls. These gene expression changes, which were seen in both human heart endothelial cells and mouse aortas, persisted for at least six days after glucose levels returned to normal. These changes were prevented by blocking methylglyoxal production.

Current treatments for diabetes are aimed at reducing mean glucose levels in patients but not the temporary rises in blood sugar levels that occur between insulin injections. This study suggests that adjusting the timing of the treatment regimen to avoid these spikes might be more effective in reducing the risk of heart disease. HB

© 2008 Rockefeller University Press
Previous articleNext article
Back to top
Download PDF
Citation Tools
The lowdown on sugar highs
Hema Bashyam
Journal of Experimental Medicine Sep 2008, 205 (10) 2183; DOI: 10.1084/jem.20510iti4

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts
Sign In to Email Alerts with your Email Address

Email logo Twitter logo Facebook logo Mendeley logo Reddit logo CiteULike logo LinkedIn logo

The Journal of Experimental Medicine: 216 (2)

Current Issue

February 4, 2019
Volume 216, No. 2

  • Table of Contents
  • All Issues

Jump To

  • Article
  • Info
  • Metrics
  • Preview PDF
 

ARTICLES

  • Current Issue
  • Newest Articles
  • Archive
  • Alerts
  • RSS feeds

FOR AUTHORS

  • Submit a Manuscript
  • Instructions for Authors

ABOUT

  • About JEM
  • Editors & Staff
  • Policies & Permissions
  • Advertise
  • Contact Us
  • Feedback
  • Newsroom
  • Privacy Policy

CONNECT WITH JEM

  • Email
  • Facebook
  • Twitter
  • RSS
  • Instagram

Online ISSN: 1540-9538
Print ISSN: 0022-1007

Copyright © 2019 JEM by Rockefeller University Press